Nevro (NYSE:NVRO) and Paradigm Medical Industries (OTCMKTS:PDMI) Financial Contrast

Paradigm Medical Industries (OTCMKTS:PDMIGet Free Report) and Nevro (NYSE:NVROGet Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership.

Insider and Institutional Ownership

95.5% of Nevro shares are owned by institutional investors. 11.1% of Paradigm Medical Industries shares are owned by insiders. Comparatively, 3.2% of Nevro shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Paradigm Medical Industries and Nevro’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Paradigm Medical Industries N/A N/A N/A
Nevro -19.17% -27.48% -13.40%

Volatility and Risk

Paradigm Medical Industries has a beta of -0.46, meaning that its stock price is 146% less volatile than the S&P 500. Comparatively, Nevro has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500.

Valuation and Earnings

This table compares Paradigm Medical Industries and Nevro’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Paradigm Medical Industries N/A N/A N/A N/A N/A
Nevro $425.17 million 0.82 -$92.21 million ($2.29) -4.15

Paradigm Medical Industries has higher earnings, but lower revenue than Nevro.

Analyst Recommendations

This is a breakdown of recent ratings for Paradigm Medical Industries and Nevro, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Paradigm Medical Industries 0 0 0 0 N/A
Nevro 2 10 1 0 1.92

Nevro has a consensus price target of $19.46, suggesting a potential upside of 104.64%.

About Paradigm Medical Industries

(Get Free Report)

Paradigm Medical Industries, Inc. develops, manufactures, sells, and markets medical devices for the early detection of glaucoma and other eye disorders in the United States. The company offers P-2000 biometric analyzer A-scans and P-2500 A-scans/pachymeters; P2700 A/B and P37-II A/B scans; blood flow analyzers for the detection and management of glaucoma and other retinal vascular disorders; P2200 pachymeter and P-2500 A-scan/pachymeters; and LD 500 and LD700 autoperimeters. It also provides corneal topographers, such as PARAVUE 300 for diagnostic and contact lens applications, as well as SURVEYOR 500 for cornea and anterior segment; PARAMAX, which analyzes the functionality of ganglion cells and identifies glaucoma suspects; P60 and P60 ACI ultrasound biomicroscopes; and PARACAM 1000, a non-contact endothelial microscope, as well as software and accessories. The company was founded in 1989 and is based in Salt Lake City, Utah.

About Nevro

(Get Free Report)

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.

Receive News & Ratings for Paradigm Medical Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paradigm Medical Industries and related companies with MarketBeat.com's FREE daily email newsletter.